0000899243-17-026161.txt : 20171114 0000899243-17-026161.hdr.sgml : 20171114 20171114070122 ACCESSION NUMBER: 0000899243-17-026161 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171113 FILED AS OF DATE: 20171114 DATE AS OF CHANGE: 20171114 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ASADORIAN RAFFI CENTRAL INDEX KEY: 0001628970 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35068 FILM NUMBER: 171198272 MAIL ADDRESS: STREET 1: TBD STREET 2: TBD CITY: TBD STATE: CA ZIP: 99999 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACELRX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001427925 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 351 GALVESTON DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-216-3500 MAIL ADDRESS: STREET 1: 351 GALVESTON DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-11-13 0 0001427925 ACELRX PHARMACEUTICALS INC ACRX 0001628970 ASADORIAN RAFFI C/O ACELRX PHARMACEUTICALS, INC. 351 GALVESTON DRIVE REDWOOD CITY CA 94063 0 1 0 0 Chief Financial Officer Common Stock 2017-11-13 4 P 0 5000 1.9421 A 12000 D /s/ Martha Adler, Attorney-In-Fact 2017-11-13